Safety and Effectiveness of Juveena™ Hydrogel System Following TCGP At High-Risk for Intrauterine Adhesions

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

April 23, 2025

Study Completion Date

April 23, 2025

Conditions
Intrauterine Adhesion
Interventions
DEVICE

Juveena Hydrogel System

Application of a novel hydrogel immediately following the transcervical procedure

Trial Locations (15)

11219

Maimonides Medical Center, Brooklyn

20010

MedStar Washington Hospital Center, Washington D.C.

27560

Duke Universtiy Health System, Morrisville

29605

Prisma Health, Greensville Memorial Hospital, Greenville

41124

University Hospitals Landerbrook, Mayfield Heights

53562

Generations Fertility Care, Middleton

60068

Dr. Charles Miller and Associates, Park Ridge

67226

Cypress Medical Research Center, Wichita

77063

Aspire Houston Fertility Institute, Houston

78712

The University of Texas at Austin Dept of Womens' Health, Austin

78731

Texas Fertility Center, Austin

85020

Arizona Gynecology Consultants, Phoenix

94158

UCSF Center for Reproductive Health, San Francisco

02462

Newton Wellesley Hospital, Newton

02451

Boston IVF, Waltham

All Listed Sponsors
lead

Rejoni Inc.

INDUSTRY